Response to Comment on: "Detection, Treatment, and Survival of Pancreatic Cancer Recurrence in the Netherlands: A Nationwide Analysis"

L A Daamen^{1

2}, V P Groot¹, H M Verkooijen², I Q Molenaar¹, H C van Santvoort¹

Affiliations

¹ Department of Surgery, Regional Academic Cancer Center Utrecht, UMC Utrecht Cancer Center & St. Antonius Hospital Nieuwegein, Utrecht, The Netherlands.
² Division of Imaging, UMC Utrecht Cancer Center, Utrecht University, Utrecht, The Netherlands.

Comment

L A Daamen et al. Ann Surg. 2022.

. 2022 Dec 1;276(6):e1124-e1125.

doi: 10.1097/SLA.0000000000005404. Epub 2022 Feb 1.

L A Daamen^{1

2}, V P Groot¹, H M Verkooijen², I Q Molenaar¹, H C van Santvoort¹

¹ Department of Surgery, Regional Academic Cancer Center Utrecht, UMC Utrecht Cancer Center & St. Antonius Hospital Nieuwegein, Utrecht, The Netherlands.
² Division of Imaging, UMC Utrecht Cancer Center, Utrecht University, Utrecht, The Netherlands.

No abstract available

Comment on

Detection, Treatment, and Survival of Pancreatic Cancer Recurrence in the Netherlands: A Nationwide Analysis.
Daamen LA, Groot VP, Besselink MG, Bosscha K, Busch OR, Cirkel GA, van Dam RM, Festen S, Groot Koerkamp B, Haj Mohammad N, van der Harst E, de Hingh IHJT, Intven MPW, Kazemier G, Los M, Meijer GJ, de Meijer VE, Nieuwenhuijs VB, Pranger BK, Raicu MG, Schreinemakers JMJ, Stommel MWJ, Verdonk RC, Verkooijen HM, Molenaar IQ, van Santvoort HC; Dutch Pancreatic Cancer Group. Daamen LA, et al. Ann Surg. 2022 Apr 1;275(4):769-775. doi: 10.1097/SLA.0000000000004093. Ann Surg. 2022. PMID: 32773631
Comment on: "Detection, Treatment, and Survival of Pancreatic Cancer Recurrence in the Netherlands: A Nationwide Analysis".
Boeck S, Heinemann V, Werner J. Boeck S, et al. Ann Surg. 2022 Dec 1;276(6):e1123-e1124. doi: 10.1097/SLA.0000000000005405. Epub 2022 Feb 1. Ann Surg. 2022. PMID: 35129463 No abstract available.

1. DaamenLAGrootVPBesselinkMG . Detection, treatment, and survival of pancreatic cancer recurrence in the Netherlands: a nationwide analysis. Ann Surg. 2022;275:769–775.
1. ClinicalTrials.gov, U.S. National Library of Medicine. Available at: https://clinicaltrials.gov/ct2/ show/NCT04875325. Accessed January 10, 2022.
1. van der VeldenJMVerkooijenHMYoung-AfatDA . The cohortmultiple randomized controlledtrial design: a valid and efficient alternative to pragmatic trials? ínt J Epidemiol. 2017;46:96–102.
1. Coebergh van denB.raak RRJvan RijssenLBvan KleefJJ . Nationwide comprehensive gastrointestinal cancer cohorts: the 3P initiative. Acta Oncol. 2018;57:195–202.
1. Young-AfatDAVerkooijenHAvan GilsCH . Brief report: staged-informed consent in the cohort multiple randomized controlled trial design [published correction appears in Epidemiology. 2016 Jul;27(4):e31]. Epidemiology. 2016;27:389–392.